← All FR Documents
Notice

Center for Scientific Review; Notice of Closed Meetings

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, National Institutes of Health. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2025-07383
TypeNotice
PublishedApr 30, 2025
Effective Date-
RIN-
Docket ID-
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

  • Incorporate requirements by reference (IBR) to external documents
  • Are procedural notices without substantive obligations
  • Contain only preamble/explanation without regulatory text

Full Document Text (599 words · ~3 min read)

Text Preserved
<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>National Institutes of Health</SUBAGY> <SUBJECT>Center for Scientific Review; Notice of Closed Meetings</SUBJECT> Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. <EXTRACT> <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel; RFA Panel: Science Mechanistic Research on Neuromodulation for Substance Use Disorder Treatment. <E T="03">Date:</E> June 2, 2025. <E T="03">Time:</E> 12:00 p.m. to 2:30 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Ipolia R Ramadan, Ph.D., Scientific Review Officer, Division of Extramural Research, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 827-4471, <E T="03">ramadanir@mail.nih.gov.</E> <E T="03">Name of Committee:</E> Healthcare Delivery and Methodologies Integrated Review Group; Science of Implementation in Health and Healthcare Study Section. <E T="03">Date:</E> June 4-5, 2025. <E T="03">Time:</E> 9:00 a.m. to 6:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Wenjuan Wang, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3154, Bethesda, MD 20892, (301) 480-8667, <E T="03">wangw22@mail.nih.gov.</E> <E T="03">Name of Committee:</E> Genes, Genomes, and Genetics Integrated Review Group; Genomics, Computational Biology and Technology Study Section. <E T="03">Date:</E> June 5-6, 2025. <E T="03">Time:</E> 9:00 a.m. to 6:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Methode Bacanamwo, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2200, Bethesda, MD 20892, 301-827-7088, <E T="03">methode.bacanamwo@nih.gov.</E> <E T="03">Name of Committee:</E> Infectious Diseases and Immunology A Integrated Review Group; Pathogenic Eukaryotes Study Section. <E T="03">Date:</E> June 5-6, 2025. <E T="03">Time:</E> 9:30 a.m. to 7:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Jennifer Chien Villa, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-496-5436, <E T="03">jennifer.villa@nih.gov.</E> <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel; RFA Panel: R01—Mitochondrial Nuclear Communication in AD/ADRD. <E T="03">Date:</E> June 17-18, 2025. <E T="03">Time:</E> 9:00 a.m. to 4:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Anita T. Tandle, Ph.D., Scientific Review Officer, Division of Extramural Activities, Scientific Review Branch, National Institute on Aging, NIH, 5601 Fishers Lane, Suite 8B, Rockville, MD 20892, (240) 204-0329, <E T="03">tandlea@mail.nih.gov.</E> <FP>(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)</FP> </EXTRACT> <SIG> <DATED>Dated: April 24, 2025.</DATED> <NAME>Bruce A. George,</NAME> Program Analyst, Office of Federal Advisory Committee Policy. </SIG> <FRDOC>[FR Doc. 2025-07383 Filed 4-29-25; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison.